The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter defibrillator

Heart Rhythm

12 Luglio Lug 2022 5 months ago
  • Tondo C

The absence of pacing capabilities may reduce the appeal of S-ICD devices for patients at risk of conduction disorders or with anti-tachycardia pacing/cardiac resynchronization (CRT) requirements. Reports of rates of S-ICD to TV-ICD system switch in real-world scenarios are limited.

Reference: The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter defibrillator. Gasperetti A, Schiavone M, Vogler J, Laredo M, Fastenrath F, Palmisano P, Ziacchi M, Angeletti A, Mitacchione G, Kaiser L, Compagnucci P, Breitenstein A, Arosio R, Vitali F, De Bonis S, Picarelli F, Casella M, Santini L, Pignalberi C, Lavalle C, Pisanò E, Ricciardi D, Calò L, Curnis A, Bertini M, Gulletta S, Dello Russo A, Badenco N, Tondo C, Kuschyk J, Tilz R, Forleo GB, Biffi M. Heart Rhythm. 2022 Jun 30:S1547-5271(22)02159-2.

Go to PubMed